カテゴリー： 世界, 医療/バイオ, QYResearch

インシリコ臨床試験の世界市場インサイト・予測（～2028年）

【英語タイトル】Global In Silico Clinical Trials Market Insights, Forecast to 2028

QYResearchが出版した調査資料（QY22JLX09238）・商品コード：QY22JLX09238
・発行会社（調査会社）：QYResearch
・発行日：2022年7月（※2025年版があります。お問い合わせください。）
・ページ数：114
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥735,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,102,500見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,470,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

COVID-19のパンデミックにより、インシリコ臨床試験のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にインシリコ臨床試験の世界市場のxxx％を占める「フェーズI」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「腫瘍学」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
インシリコ臨床試験の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのインシリコ臨床試験市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

インシリコ臨床試験のグローバル主要企業には、Certara, Inc.、Novadiscovery Sas、Insilico Medicine, Inc.、Dassault Systemes SE、GNS Healthcare Inc.、The AnyLogic Company、InSilicoTrials、Immunetrics Inc.、Nuventra Pharma Sciences、Abzena Ltd.、Siemensなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

インシリコ臨床試験市場は、種類と用途によって区分されます。世界のインシリコ臨床試験市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
フェーズI、フェーズII、フェーズIII、フェーズIV

【用途別セグメント】
腫瘍学、感染症、血液学、心臓病学、皮膚科、神経学、糖尿病、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- インシリコ臨床試験製品概要
- 種類別市場（フェーズI、フェーズII、フェーズIII、フェーズIV）
- 用途別市場（腫瘍学、感染症、血液学、心臓病学、皮膚科、神経学、糖尿病、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界のインシリコ臨床試験販売量予測2017-2028
- 世界のインシリコ臨床試験売上予測2017-2028
- インシリコ臨床試験の地域別販売量
- インシリコ臨床試験の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別インシリコ臨床試験販売量
- 主要メーカー別インシリコ臨床試験売上
- 主要メーカー別インシリコ臨床試験価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（フェーズI、フェーズII、フェーズIII、フェーズIV）
- インシリコ臨床試験の種類別販売量
- インシリコ臨床試験の種類別売上
- インシリコ臨床試験の種類別価格
・用途別市場規模（腫瘍学、感染症、血液学、心臓病学、皮膚科、神経学、糖尿病、その他）
- インシリコ臨床試験の用途別販売量
- インシリコ臨床試験の用途別売上
- インシリコ臨床試験の用途別価格
・北米市場
- 北米のインシリコ臨床試験市場規模（種類別、用途別）
- 主要国別のインシリコ臨床試験市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのインシリコ臨床試験市場規模（種類別、用途別）
- 主要国別のインシリコ臨床試験市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のインシリコ臨床試験市場規模（種類別、用途別）
- 主要国別のインシリコ臨床試験市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のインシリコ臨床試験市場規模（種類別、用途別）
- 主要国別のインシリコ臨床試験市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのインシリコ臨床試験市場規模（種類別、用途別）
- 主要国別のインシリコ臨床試験市場規模（トルコ、サウジアラビア）
・企業情報
Certara, Inc.、Novadiscovery Sas、Insilico Medicine, Inc.、Dassault Systemes SE、GNS Healthcare Inc.、The AnyLogic Company、InSilicoTrials、Immunetrics Inc.、Nuventra Pharma Sciences、Abzena Ltd.、Siemens
・産業チェーン及び販売チャネル分析
- インシリコ臨床試験の産業チェーン分析
- インシリコ臨床試験の原材料
- インシリコ臨床試験の生産プロセス
- インシリコ臨床試験の販売及びマーケティング
- インシリコ臨床試験の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- インシリコ臨床試験の産業動向
- インシリコ臨床試験のマーケットドライバー
- インシリコ臨床試験の課題
- インシリコ臨床試験の阻害要因
・主な調査結果

An in silico clinical trial, also known as a virtual clinical trial, is an individualized computer simulation used in the development or regulatory evaluation of a medicinal product, device, or intervention. While completely simulated clinical trials are not feasible with current technology and understanding of biology, its development would be expected to have major benefits over current in vivo clinical trials, and research on it is being pursued.
Market Analysis and Insights: Global In Silico Clinical Trials Market
The global In Silico Clinical Trials market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Phase I accounting for % of the In Silico Clinical Trials global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Oncology segment is altered to an % CAGR throughout this forecast period.
China In Silico Clinical Trials market size is valued at US$ million in 2021, while the North America and Europe In Silico Clinical Trials are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe In Silico Clinical Trials landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global In Silico Clinical Trials market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global In Silico Clinical Trials market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global In Silico Clinical Trials market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global In Silico Clinical Trials market.
Global In Silico Clinical Trials Scope and Market Size
In Silico Clinical Trials market is segmented by players, region (country), by Phase and by Application. Players, stakeholders, and other participants in the global In Silico Clinical Trials market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Phase and by Application for the period 2017-2028.
Segment by Phase
Phase I
Phase II
Phase III
Phase IV
Segment by Application
Oncology
Infectious Disease
Hematology
Cardiology
Dermatology
Neurology
Diabetes
Others
By Company
Certara, Inc.
Novadiscovery Sas
Insilico Medicine, Inc.
Dassault Systemes SE
GNS Healthcare Inc.
The AnyLogic Company
InSilicoTrials
Immunetrics Inc.
Nuventra Pharma Sciences
Abzena Ltd.
Siemens
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

❖ レポートの目次 ❖

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Phase
1.2.1 Global In Silico Clinical Trials Market Size Growth Rate by Phase, 2017 VS 2021 VS 2028
1.2.2 Phase I
1.2.3 Phase II
1.2.4 Phase III
1.2.5 Phase IV
1.3 Market by Application
1.3.1 Global In Silico Clinical Trials Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 Infectious Disease
1.3.4 Hematology
1.3.5 Cardiology
1.3.6 Dermatology
1.3.7 Neurology
1.3.8 Diabetes
1.3.9 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global In Silico Clinical Trials Market Perspective (2017-2028)
2.2 In Silico Clinical Trials Growth Trends by Region
2.2.1 In Silico Clinical Trials Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 In Silico Clinical Trials Historic Market Size by Region (2017-2022)
2.2.3 In Silico Clinical Trials Forecasted Market Size by Region (2023-2028)
2.3 In Silico Clinical Trials Market Dynamics
2.3.1 In Silico Clinical Trials Industry Trends
2.3.2 In Silico Clinical Trials Market Drivers
2.3.3 In Silico Clinical Trials Market Challenges
2.3.4 In Silico Clinical Trials Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Silico Clinical Trials Players by Revenue
3.1.1 Global Top In Silico Clinical Trials Players by Revenue (2017-2022)
3.1.2 Global In Silico Clinical Trials Revenue Market Share by Players (2017-2022)
3.2 Global In Silico Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In Silico Clinical Trials Revenue
3.4 Global In Silico Clinical Trials Market Concentration Ratio
3.4.1 Global In Silico Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Silico Clinical Trials Revenue in 2021
3.5 In Silico Clinical Trials Key Players Head office and Area Served
3.6 Key Players In Silico Clinical Trials Product Solution and Service
3.7 Date of Enter into In Silico Clinical Trials Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In Silico Clinical Trials Breakdown Data by Phase
4.1 Global In Silico Clinical Trials Historic Market Size by Phase (2017-2022)
4.2 Global In Silico Clinical Trials Forecasted Market Size by Phase (2023-2028)
5 In Silico Clinical Trials Breakdown Data by Application
5.1 Global In Silico Clinical Trials Historic Market Size by Application (2017-2022)
5.2 Global In Silico Clinical Trials Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America In Silico Clinical Trials Market Size (2017-2028)
6.2 North America In Silico Clinical Trials Market Size by Phase
6.2.1 North America In Silico Clinical Trials Market Size by Phase (2017-2022)
6.2.2 North America In Silico Clinical Trials Market Size by Phase (2023-2028)
6.2.3 North America In Silico Clinical Trials Market Share by Phase (2017-2028)
6.3 North America In Silico Clinical Trials Market Size by Application
6.3.1 North America In Silico Clinical Trials Market Size by Application (2017-2022)
6.3.2 North America In Silico Clinical Trials Market Size by Application (2023-2028)
6.3.3 North America In Silico Clinical Trials Market Share by Application (2017-2028)
6.4 North America In Silico Clinical Trials Market Size by Country
6.4.1 North America In Silico Clinical Trials Market Size by Country (2017-2022)
6.4.2 North America In Silico Clinical Trials Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe In Silico Clinical Trials Market Size (2017-2028)
7.2 Europe In Silico Clinical Trials Market Size by Phase
7.2.1 Europe In Silico Clinical Trials Market Size by Phase (2017-2022)
7.2.2 Europe In Silico Clinical Trials Market Size by Phase (2023-2028)
7.2.3 Europe In Silico Clinical Trials Market Share by Phase (2017-2028)
7.3 Europe In Silico Clinical Trials Market Size by Application
7.3.1 Europe In Silico Clinical Trials Market Size by Application (2017-2022)
7.3.2 Europe In Silico Clinical Trials Market Size by Application (2023-2028)
7.3.3 Europe In Silico Clinical Trials Market Share by Application (2017-2028)
7.4 Europe In Silico Clinical Trials Market Size by Country
7.4.1 Europe In Silico Clinical Trials Market Size by Country (2017-2022)
7.4.2 Europe In Silico Clinical Trials Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In Silico Clinical Trials Market Size (2017-2028)
8.2 Asia-Pacific In Silico Clinical Trials Market Size by Phase
8.2.1 Asia-Pacific In Silico Clinical Trials Market Size by Phase (2017-2022)
8.2.2 Asia-Pacific In Silico Clinical Trials Market Size by Phase (2023-2028)
8.2.3 Asia-Pacific In Silico Clinical Trials Market Share by Phase (2017-2028)
8.3 Asia-Pacific In Silico Clinical Trials Market Size by Application
8.3.1 Asia-Pacific In Silico Clinical Trials Market Size by Application (2017-2022)
8.3.2 Asia-Pacific In Silico Clinical Trials Market Size by Application (2023-2028)
8.3.3 Asia-Pacific In Silico Clinical Trials Market Share by Application (2017-2028)
8.4 Asia-Pacific In Silico Clinical Trials Market Size by Region
8.4.1 Asia-Pacific In Silico Clinical Trials Market Size by Region (2017-2022)
8.4.2 Asia-Pacific In Silico Clinical Trials Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America In Silico Clinical Trials Market Size (2017-2028)
9.2 Latin America In Silico Clinical Trials Market Size by Phase
9.2.1 Latin America In Silico Clinical Trials Market Size by Phase (2017-2022)
9.2.2 Latin America In Silico Clinical Trials Market Size by Phase (2023-2028)
9.2.3 Latin America In Silico Clinical Trials Market Share by Phase (2017-2028)
9.3 Latin America In Silico Clinical Trials Market Size by Application
9.3.1 Latin America In Silico Clinical Trials Market Size by Application (2017-2022)
9.3.2 Latin America In Silico Clinical Trials Market Size by Application (2023-2028)
9.3.3 Latin America In Silico Clinical Trials Market Share by Application (2017-2028)
9.4 Latin America In Silico Clinical Trials Market Size by Country
9.4.1 Latin America In Silico Clinical Trials Market Size by Country (2017-2022)
9.4.2 Latin America In Silico Clinical Trials Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Silico Clinical Trials Market Size (2017-2028)
10.2 Middle East & Africa In Silico Clinical Trials Market Size by Phase
10.2.1 Middle East & Africa In Silico Clinical Trials Market Size by Phase (2017-2022)
10.2.2 Middle East & Africa In Silico Clinical Trials Market Size by Phase (2023-2028)
10.2.3 Middle East & Africa In Silico Clinical Trials Market Share by Phase (2017-2028)
10.3 Middle East & Africa In Silico Clinical Trials Market Size by Application
10.3.1 Middle East & Africa In Silico Clinical Trials Market Size by Application (2017-2022)
10.3.2 Middle East & Africa In Silico Clinical Trials Market Size by Application (2023-2028)
10.3.3 Middle East & Africa In Silico Clinical Trials Market Share by Application (2017-2028)
10.4 Middle East & Africa In Silico Clinical Trials Market Size by Country
10.4.1 Middle East & Africa In Silico Clinical Trials Market Size by Country (2017-2022)
10.4.2 Middle East & Africa In Silico Clinical Trials Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Certara, Inc.
11.1.1 Certara, Inc. Company Details
11.1.2 Certara, Inc. Business Overview
11.1.3 Certara, Inc. In Silico Clinical Trials Introduction
11.1.4 Certara, Inc. Revenue in In Silico Clinical Trials Business (2017-2022)
11.1.5 Certara, Inc. Recent Developments
11.2 Novadiscovery Sas
11.2.1 Novadiscovery Sas Company Details
11.2.2 Novadiscovery Sas Business Overview
11.2.3 Novadiscovery Sas In Silico Clinical Trials Introduction
11.2.4 Novadiscovery Sas Revenue in In Silico Clinical Trials Business (2017-2022)
11.2.5 Novadiscovery Sas Recent Developments
11.3 Insilico Medicine, Inc.
11.3.1 Insilico Medicine, Inc. Company Details
11.3.2 Insilico Medicine, Inc. Business Overview
11.3.3 Insilico Medicine, Inc. In Silico Clinical Trials Introduction
11.3.4 Insilico Medicine, Inc. Revenue in In Silico Clinical Trials Business (2017-2022)
11.3.5 Insilico Medicine, Inc. Recent Developments
11.4 Dassault Systemes SE
11.4.1 Dassault Systemes SE Company Details
11.4.2 Dassault Systemes SE Business Overview
11.4.3 Dassault Systemes SE In Silico Clinical Trials Introduction
11.4.4 Dassault Systemes SE Revenue in In Silico Clinical Trials Business (2017-2022)
11.4.5 Dassault Systemes SE Recent Developments
11.5 GNS Healthcare Inc.
11.5.1 GNS Healthcare Inc. Company Details
11.5.2 GNS Healthcare Inc. Business Overview
11.5.3 GNS Healthcare Inc. In Silico Clinical Trials Introduction
11.5.4 GNS Healthcare Inc. Revenue in In Silico Clinical Trials Business (2017-2022)
11.5.5 GNS Healthcare Inc. Recent Developments
11.6 The AnyLogic Company
11.6.1 The AnyLogic Company Company Details
11.6.2 The AnyLogic Company Business Overview
11.6.3 The AnyLogic Company In Silico Clinical Trials Introduction
11.6.4 The AnyLogic Company Revenue in In Silico Clinical Trials Business (2017-2022)
11.6.5 The AnyLogic Company Recent Developments
11.7 InSilicoTrials
11.7.1 InSilicoTrials Company Details
11.7.2 InSilicoTrials Business Overview
11.7.3 InSilicoTrials In Silico Clinical Trials Introduction
11.7.4 InSilicoTrials Revenue in In Silico Clinical Trials Business (2017-2022)
11.7.5 InSilicoTrials Recent Developments
11.8 Immunetrics Inc.
11.8.1 Immunetrics Inc. Company Details
11.8.2 Immunetrics Inc. Business Overview
11.8.3 Immunetrics Inc. In Silico Clinical Trials Introduction
11.8.4 Immunetrics Inc. Revenue in In Silico Clinical Trials Business (2017-2022)
11.8.5 Immunetrics Inc. Recent Developments
11.9 Nuventra Pharma Sciences
11.9.1 Nuventra Pharma Sciences Company Details
11.9.2 Nuventra Pharma Sciences Business Overview
11.9.3 Nuventra Pharma Sciences In Silico Clinical Trials Introduction
11.9.4 Nuventra Pharma Sciences Revenue in In Silico Clinical Trials Business (2017-2022)
11.9.5 Nuventra Pharma Sciences Recent Developments
11.10 Abzena Ltd.
11.10.1 Abzena Ltd. Company Details
11.10.2 Abzena Ltd. Business Overview
11.10.3 Abzena Ltd. In Silico Clinical Trials Introduction
11.10.4 Abzena Ltd. Revenue in In Silico Clinical Trials Business (2017-2022)
11.10.5 Abzena Ltd. Recent Developments
11.11 Siemens
11.11.1 Siemens Company Details
11.11.2 Siemens Business Overview
11.11.3 Siemens In Silico Clinical Trials Introduction
11.11.4 Siemens Revenue in In Silico Clinical Trials Business (2017-2022)
11.11.5 Siemens Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global In Silico Clinical Trials Market Size Growth Rate by Phase (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Phase I
Table 3. Key Players of Phase II
Table 4. Key Players of Phase III
Table 5. Key Players of Phase IV
Table 6. Global In Silico Clinical Trials Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global In Silico Clinical Trials Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global In Silico Clinical Trials Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global In Silico Clinical Trials Market Share by Region (2017-2022)
Table 10. Global In Silico Clinical Trials Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global In Silico Clinical Trials Market Share by Region (2023-2028)
Table 12. In Silico Clinical Trials Market Trends
Table 13. In Silico Clinical Trials Market Drivers
Table 14. In Silico Clinical Trials Market Challenges
Table 15. In Silico Clinical Trials Market Restraints
Table 16. Global In Silico Clinical Trials Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global In Silico Clinical Trials Revenue Share by Players (2017-2022)
Table 18. Global Top In Silico Clinical Trials by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Silico Clinical Trials as of 2021)
Table 19. Ranking of Global Top In Silico Clinical Trials Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by In Silico Clinical Trials Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players In Silico Clinical Trials Product Solution and Service
Table 23. Date of Enter into In Silico Clinical Trials Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global In Silico Clinical Trials Market Size by Phase (2017-2022) & (US$ Million)
Table 26. Global In Silico Clinical Trials Revenue Market Share by Phase (2017-2022)
Table 27. Global In Silico Clinical Trials Forecasted Market Size by Phase (2023-2028) & (US$ Million)
Table 28. Global In Silico Clinical Trials Revenue Market Share by Phase (2023-2028)
Table 29. Global In Silico Clinical Trials Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global In Silico Clinical Trials Revenue Share by Application (2017-2022)
Table 31. Global In Silico Clinical Trials Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global In Silico Clinical Trials Revenue Share by Application (2023-2028)
Table 33. North America In Silico Clinical Trials Market Size by Phase (2017-2022) & (US$ Million)
Table 34. North America In Silico Clinical Trials Market Size by Phase (2023-2028) & (US$ Million)
Table 35. North America In Silico Clinical Trials Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America In Silico Clinical Trials Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America In Silico Clinical Trials Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America In Silico Clinical Trials Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe In Silico Clinical Trials Market Size by Phase (2017-2022) & (US$ Million)
Table 40. Europe In Silico Clinical Trials Market Size by Phase (2023-2028) & (US$ Million)
Table 41. Europe In Silico Clinical Trials Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe In Silico Clinical Trials Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe In Silico Clinical Trials Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe In Silico Clinical Trials Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific In Silico Clinical Trials Market Size by Phase (2017-2022) & (US$ Million)
Table 46. Asia Pacific In Silico Clinical Trials Market Size by Phase (2023-2028) & (US$ Million)
Table 47. Asia Pacific In Silico Clinical Trials Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific In Silico Clinical Trials Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific In Silico Clinical Trials Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific In Silico Clinical Trials Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America In Silico Clinical Trials Market Size by Phase (2017-2022) & (US$ Million)
Table 52. Latin America In Silico Clinical Trials Market Size by Phase (2023-2028) & (US$ Million)
Table 53. Latin America In Silico Clinical Trials Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America In Silico Clinical Trials Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America In Silico Clinical Trials Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America In Silico Clinical Trials Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa In Silico Clinical Trials Market Size by Phase (2017-2022) & (US$ Million)
Table 58. Middle East and Africa In Silico Clinical Trials Market Size by Phase (2023-2028) & (US$ Million)
Table 59. Middle East and Africa In Silico Clinical Trials Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa In Silico Clinical Trials Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa In Silico Clinical Trials Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa In Silico Clinical Trials Market Size by Country (2023-2028) & (US$ Million)
Table 63. Certara, Inc. Company Details
Table 64. Certara, Inc. Business Overview
Table 65. Certara, Inc. In Silico Clinical Trials Product
Table 66. Certara, Inc. Revenue in In Silico Clinical Trials Business (2017-2022) & (US$ Million)
Table 67. Certara, Inc. Recent Developments
Table 68. Novadiscovery Sas Company Details
Table 69. Novadiscovery Sas Business Overview
Table 70. Novadiscovery Sas In Silico Clinical Trials Product
Table 71. Novadiscovery Sas Revenue in In Silico Clinical Trials Business (2017-2022) & (US$ Million)
Table 72. Novadiscovery Sas Recent Developments
Table 73. Insilico Medicine, Inc. Company Details
Table 74. Insilico Medicine, Inc. Business Overview
Table 75. Insilico Medicine, Inc. In Silico Clinical Trials Product
Table 76. Insilico Medicine, Inc. Revenue in In Silico Clinical Trials Business (2017-2022) & (US$ Million)
Table 77. Insilico Medicine, Inc. Recent Developments
Table 78. Dassault Systemes SE Company Details
Table 79. Dassault Systemes SE Business Overview
Table 80. Dassault Systemes SE In Silico Clinical Trials Product
Table 81. Dassault Systemes SE Revenue in In Silico Clinical Trials Business (2017-2022) & (US$ Million)
Table 82. Dassault Systemes SE Recent Developments
Table 83. GNS Healthcare Inc. Company Details
Table 84. GNS Healthcare Inc. Business Overview
Table 85. GNS Healthcare Inc. In Silico Clinical Trials Product
Table 86. GNS Healthcare Inc. Revenue in In Silico Clinical Trials Business (2017-2022) & (US$ Million)
Table 87. GNS Healthcare Inc. Recent Developments
Table 88. The AnyLogic Company Company Details
Table 89. The AnyLogic Company Business Overview
Table 90. The AnyLogic Company In Silico Clinical Trials Product
Table 91. The AnyLogic Company Revenue in In Silico Clinical Trials Business (2017-2022) & (US$ Million)
Table 92. The AnyLogic Company Recent Developments
Table 93. InSilicoTrials Company Details
Table 94. InSilicoTrials Business Overview
Table 95. InSilicoTrials In Silico Clinical Trials Product
Table 96. InSilicoTrials Revenue in In Silico Clinical Trials Business (2017-2022) & (US$ Million)
Table 97. InSilicoTrials Recent Developments
Table 98. Immunetrics Inc. Company Details
Table 99. Immunetrics Inc. Business Overview
Table 100. Immunetrics Inc. In Silico Clinical Trials Product
Table 101. Immunetrics Inc. Revenue in In Silico Clinical Trials Business (2017-2022) & (US$ Million)
Table 102. Immunetrics Inc. Recent Developments
Table 103. Nuventra Pharma Sciences Company Details
Table 104. Nuventra Pharma Sciences Business Overview
Table 105. Nuventra Pharma Sciences In Silico Clinical Trials Product
Table 106. Nuventra Pharma Sciences Revenue in In Silico Clinical Trials Business (2017-2022) & (US$ Million)
Table 107. Nuventra Pharma Sciences Recent Developments
Table 108. Abzena Ltd. Company Details
Table 109. Abzena Ltd. Business Overview
Table 110. Abzena Ltd. In Silico Clinical Trials Product
Table 111. Abzena Ltd. Revenue in In Silico Clinical Trials Business (2017-2022) & (US$ Million)
Table 112. Abzena Ltd. Recent Developments
Table 113. Siemens Company Details
Table 114. Siemens Business Overview
Table 115. Siemens In Silico Clinical Trials Product
Table 116. Siemens Revenue in In Silico Clinical Trials Business (2017-2022) & (US$ Million)
Table 117. Siemens Recent Developments
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global In Silico Clinical Trials Market Share by Phase: 2021 VS 2028
Figure 2. Phase I Features
Figure 3. Phase II Features
Figure 4. Phase III Features
Figure 5. Phase IV Features
Figure 6. Global In Silico Clinical Trials Market Share by Application: 2021 VS 2028
Figure 7. Oncology Case Studies
Figure 8. Infectious Disease Case Studies
Figure 9. Hematology Case Studies
Figure 10. Cardiology Case Studies
Figure 11. Dermatology Case Studies
Figure 12. Neurology Case Studies
Figure 13. Diabetes Case Studies
Figure 14. Others Case Studies
Figure 15. In Silico Clinical Trials Report Years Considered
Figure 16. Global In Silico Clinical Trials Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 17. Global In Silico Clinical Trials Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 18. Global In Silico Clinical Trials Market Share by Region: 2021 VS 2028
Figure 19. Global In Silico Clinical Trials Market Share by Players in 2021
Figure 20. Global Top In Silico Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Silico Clinical Trials as of 2021)
Figure 21. The Top 10 and 5 Players Market Share by In Silico Clinical Trials Revenue in 2021
Figure 22. North America In Silico Clinical Trials Market Size YoY (2017-2028) & (US$ Million)
Figure 23. North America In Silico Clinical Trials Market Size Market Share by Phase (2017-2028)
Figure 24. North America In Silico Clinical Trials Market Size Market Share by Application (2017-2028)
Figure 25. North America In Silico Clinical Trials Market Size Share by Country (2017-2028)
Figure 26. United States In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Canada In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Europe In Silico Clinical Trials Market Size YoY (2017-2028) & (US$ Million)
Figure 29. Europe In Silico Clinical Trials Market Size Market Share by Phase (2017-2028)
Figure 30. Europe In Silico Clinical Trials Market Size Market Share by Application (2017-2028)
Figure 31. Europe In Silico Clinical Trials Market Size Share by Country (2017-2028)
Figure 32. Germany In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. France In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. U.K. In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Italy In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Russia In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Nordic Countries In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Asia-Pacific In Silico Clinical Trials Market Size YoY (2017-2028) & (US$ Million)
Figure 39. Asia Pacific In Silico Clinical Trials Market Size Market Share by Phase (2017-2028)
Figure 40. Asia Pacific In Silico Clinical Trials Market Size Market Share by Application (2017-2028)
Figure 41. Asia Pacific In Silico Clinical Trials Market Size Share by Region (2017-2028)
Figure 42. China In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Japan In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. South Korea In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Southeast Asia In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. India In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Australia In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 48. Latin America In Silico Clinical Trials Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Latin America In Silico Clinical Trials Market Size Market Share by Phase (2017-2028)
Figure 50. Latin America In Silico Clinical Trials Market Size Market Share by Application (2017-2028)
Figure 51. Latin America In Silico Clinical Trials Market Size Share by Country (2017-2028)
Figure 52. Mexico In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Brazil In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Middle East & Africa In Silico Clinical Trials Market Size YoY (2017-2028) & (US$ Million)
Figure 55. Middle East and Africa In Silico Clinical Trials Market Size Market Share by Phase (2017-2028)
Figure 56. Middle East and Africa In Silico Clinical Trials Market Size Market Share by Application (2017-2028)
Figure 57. Middle East and Africa In Silico Clinical Trials Market Size Share by Country (2017-2028)
Figure 58. Turkey In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 59. Saudi Arabia In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 60. UAE In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 61. Certara, Inc. Revenue Growth Rate in In Silico Clinical Trials Business (2017-2022)
Figure 62. Novadiscovery Sas Revenue Growth Rate in In Silico Clinical Trials Business (2017-2022)
Figure 63. Insilico Medicine, Inc. Revenue Growth Rate in In Silico Clinical Trials Business (2017-2022)
Figure 64. Dassault Systemes SE Revenue Growth Rate in In Silico Clinical Trials Business (2017-2022)
Figure 65. GNS Healthcare Inc. Revenue Growth Rate in In Silico Clinical Trials Business (2017-2022)
Figure 66. The AnyLogic Company Revenue Growth Rate in In Silico Clinical Trials Business (2017-2022)
Figure 67. InSilicoTrials Revenue Growth Rate in In Silico Clinical Trials Business (2017-2022)
Figure 68. Immunetrics Inc. Revenue Growth Rate in In Silico Clinical Trials Business (2017-2022)
Figure 69. Nuventra Pharma Sciences Revenue Growth Rate in In Silico Clinical Trials Business (2017-2022)
Figure 70. Abzena Ltd. Revenue Growth Rate in In Silico Clinical Trials Business (2017-2022)
Figure 71. Siemens Revenue Growth Rate in In Silico Clinical Trials Business (2017-2022)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed


★調査レポート[インシリコ臨床試験の世界市場インサイト・予測（～2028年）] (コード：QY22JLX09238)販売に関する免責事項を必ずご確認ください。
★調査レポート[インシリコ臨床試験の世界市場インサイト・予測（～2028年）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 臨床試験被験者募集の世界市場インサイト・予測（～2028年）
  • オミクス系臨床試験の世界市場インサイト・予測（～2028年）
  • 臨床試験募集＆管理サービスの世界市場インサイト・予測（～2028年）
  • 第I～IV相臨床開発サービスの世界市場インサイト・予測（～2028年）
  • 低炭素シリコマンガン（LCSiMn）の世界市場インサイト・予測（～2028年）

    • ◆H&Iグローバルリサーチのお客様（例）◆